QPID Health is a clinical intelligence platform designed to extract meaningful clinical information at the patient level from any electronic health record (EHR) through a unique and powerful medical concept based NLP (Natural Language Processing) search engine. The technology extracts from the EHR data repository and highlights for caregivers the most relevant clinical information at…

Read More



RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body’s own cells. By targeting specific genes, RaNA’s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease.

Read More

Raze Therapeutics


Raze Therapeutics, is developing the next generation of oncology therapeutics that target metabolic pathways essential to cancer growth and survival. Using their proprietary platform, they are developing a pipeline of selective therapeutics for specific solid and hematologic cancers.

Read More


Sebacia is developing a safe and durable treatment for acne that utilizes a laser-activated topical agent.

Read More

Spero Therapeutics


Spero Therapeutics is a product-focused biopharmaceutical company developing a pipeline of novel treatments for bacterial infections. The company’s pipeline of anti-infective agents is one of the most unique in the industry – focused exclusively on gram-negative bacterial infections.

Read More



Syntimmune is developing novel therapies for inflammatory diseases and life-threatening toxicities.

Read More

Life Image, Inc.


lifeIMAGE, Inc. created and supplies the leading platform for instant, electronic and secure medical image exchange created to address problems associated with lack of access to patients’ medical-imaging history. lifeIMAGE is the largest and most utilized network for the exchange of medical images. It has been used by 67,000 members to exchange more than 1.5…

Read More

Lysomal Therapeutics


Lysosomal Therapeutics, is developing first-in-class therapies for neurological diseases with high unmet need. LTI is leveraging its world-class knowledge of lysosomal biology and drug development to deliver innovative agents for neurodegenerative disease.

Read More

Adheron Therapeutics


Adheron Therapeutics (formerly Synovex) is a clinical stage company developing novel treatments for fibrotic diseases. The company has reported a favorable profile in a Phase I study performed with the lead product, SDP051.

Read More

Annovation Biopharma, Inc.


Annovation Biopharma was founded to create safer and easier-to-administer general anesthetic agents with financing led by Mass General Brigham Innovation Fund. The company was acquired upon demonstration of clinical proof of concept by The Medicines Company in 2015.

Read More

BioBehavioral Diagnostics


BioBehavioral Diagnostics (acquired by Pearson) was formed in 2004 to develop instrumentation for objective assessment and management of Attention Deficit Hyperactivity Disorder (ADHD), including medication response. The technology utilizes a set of proprietary bio-surrogate measurements to enable the accurate assessment and management of ADHD.

Read More


CoStim developed novel biologics targeting immune checkpoint inhibitors for oncology indications. CoStim was acquired by Novartis in 2014.

Read More